Results 11 to 20 of about 97,795 (300)

Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer

open access: yesClinics, 2016
OBJECTIVES: Pathological complete response has shown a better prognosis for patients with locally advanced rectal cancer after preoperative chemoradiotherapy.
Jianhong Peng   +12 more
doaj   +3 more sources

Targeting LDHA Palmitoylation Sensitizes GBM to Chemoradiotherapy via Suppressing Palmitic Acid Induced Glycolytic Reprogramming. [PDF]

open access: yesAdv Sci (Weinh)
Mesenchymal GSCs preferentially uptake palmitic acid, thereby promoting ZDHHC12‐mediated LDHA palmitoylation. This modification enhances LDHA enzymatic activity, drives glycolytic reprogramming, and facilitates exosomal LDHA‐mediated TAM regulation.
Gao Z   +20 more
europepmc   +2 more sources

Improving chemoradiotherapy with nanoparticle therapeutics [PDF]

open access: yes, 2013
Chemoradiotherapy has been a key treatment paradigm in cancer management. One of the main research objectives in cancer research has been to identify agents and strategies to improve the therapeutic index of chemoradiation.
Wang, Andrew Zhuang   +1 more
core   +1 more source

Overall survival with subgroups for chemotherapy and chemoradiotherapy.

open access: yes, 2023
Overall survival with subgroups for chemotherapy and chemoradiotherapy.
Liang Yang (15035)   +3 more
core   +1 more source

R0 resection rate with subgroups for chemotherapy and chemoradiotherapy.

open access: yes, 2023
R0 resection rate with subgroups for chemotherapy and chemoradiotherapy.
Liang Yang (15035)   +3 more
core   +1 more source

A novel sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and therapeutic response in pancreatic adenocarcinoma

open access: yesHeliyon
Sphingolipid metabolism affects prognosis and resistance to immunotherapy in patients with cancer and is an emerging target in cancer therapy with promising diagnostic and prognostic value.
Xiaolan He   +6 more
doaj   +1 more source

Complete pathologic response as a prognostic factor for squamous cell carcinoma of the oropharynx post-chemoradiotherapy

open access: yes, 2015
INTRODUCTION: Chemoradiotherapy for squamous cell carcinoma of the oropharynx (SCCO) provides good results for locoregional disease control, with high rates of complete clinical and pathologic responses, mainly in the neck.
Auro Del Giglio (12813424)   +6 more
core   +1 more source

Subgroup analysis of OS stratified by adjuvant radiotherapy and chemoradiotherapy.

open access: yes, 2020
A, adjuvant radiotherapy; B, adjuvant chemoradiotherapy.
Lei Wang (6656)   +5 more
core   +1 more source

The effects of cancer therapies on physical fitness before oesophagogastric cancer surgery: a prospective, blinded, multi-centre, observational, cohort study [version 1; peer review: 2 approved]

open access: yesNIHR Open Research, 2021
Background: Neoadjuvant cancer treatment is associated with improved survival following major oesophagogastric cancer surgery. The impact of neoadjuvant chemo/chemoradiotherapy on physical fitness and operative outcomes is however unclear.
Lisa Loughney   +11 more
doaj   +1 more source

Clinicopathological characteristics of patients with esophageal cancer after neoadjuvant chemoradiotherapy.

open access: yes, 2022
Clinicopathological characteristics of patients with esophageal cancer after neoadjuvant chemoradiotherapy.
Chung-Ping Hsu (205422)   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy